Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

NCT06872489 · clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Second Life Therapeutics